Localization of the Subthalamic Nucleus: Optimization with Susceptibility-Weighted Phase MR Imaging

References

1. 1.↵
   1. Wichmann T,
   2. Delong MR

   . Deep brain stimulation for neurologic and neuropsychiatric disorders. Neuron 2006;52:197–204

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Krauss JK,
   2. Jankovic J

   1. Benabid AL,
   2. Pollak P,
   3. Loudsie A,
   4. et al

   . Electrical inhibition of the subthalamic nucleus for treatment of Parkinson's disease. In: Krauss JK, Jankovic J eds. Surgery for Parkinson's Disease and Movement Disorders. Philadelphia: Lippincott Williams & Wilkins; 2001:176–87
3. 3.↵
   1. Hallgren P,
   2. Sourrander B

   . The effect of age on the non-haemin iron in the human brain. J Neurochem 1958;3:41–51

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Schenck JF,
   2. Zimmerman EA

   . High-field magnetic resonance imaging of brain iron: birth of a biomarker? NMR Biomed 2004;17:433–45

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Kitajima M,
   2. Korogi Y,
   3. Kakeda S,
   4. et al

   . Human subthalamic nucleus: evaluation with high-resolution MR imaging at 3.0T. Neuroradiology 2008;50:675–81

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Elolf E,
   2. Bockermann V,
   3. Gringel T,
   4. et al

   . Improved visibility of the subthalamic nucleus on high-resolution stereotactic MR imaging by added susceptibility (T2*) contrast using multiple gradient echoes. AJNR Am J Neuroradiol 2007;28:1093–94

   Abstract/FREE Full Text
7. 7.↵
   1. Reichenbach JR,
   2. Venkatesan R,
   3. Schillinger D,
   4. et al

   . Small vessels in the human brain: MR-venography with deoxyhemoglobin as an intrinsic contrast agent. Radiology 1997;204:272–77

   PubMedWeb of Science
8. 8.↵
   1. Haacke EM,
   2. Xu Y,
   3. Cheng YC,
   4. et al

   . Susceptibility-weighted imaging (SWI). Magn Reson Med 2004;52:612–18

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Mittal S,
   2. Wu Z,
   3. Neelavalli J,
   4. et al

   . Susceptibility-weighted imaging: technical aspects and clinical applications, part 2. AJNR Am J Neuroradiol 2009;30:232–52

   Abstract/FREE Full Text
10. 10.↵
    1. Manova ES,
    2. Habib CA,
    3. Boikov AS,
    4. et al

    . Characterizing the mesencephalon using susceptibility-weighted imaging. AJNR Am J Neuroradiol 2009;30:569–74. Epub 2008 Dec 26

    Abstract/FREE Full Text
11. 11.↵
    1. Rauscher A,
    2. Sedlacik J,
    3. Barth M,
    4. et al

    . Magnetic susceptibility-weighted MR phase imaging of the human brain. AJNR Am J Neuroradiol 2005;26:736–42

    Abstract/FREE Full Text
12. 12.↵
    1. Duyn JH,
    2. van Gelderen P,
    3. Li TQ,
    4. et al

    . High-field MRI of brain cortical substructure based on signal phase. Proc Natl Acad Sci U S A 2007;104:11796–801

    Abstract/FREE Full Text
13. 13.↵
    1. Pruessmann KP,
    2. Weiger M,
    3. Scheidegger MB,
    4. et al

    . SENSE: sensitivity encoding for fast MRI. Magn Reson Med 1999;42:952–62

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Witoszynskyj S,
    2. Rauscher A,
    3. Reichenbach JR,
    4. et al

    . Phase unwrapping of MR images using phi UN: a fast and robust region growing algorithm. Med Image Anal 2009;13:257–68. Epub 2008 Oct 18

    CrossRefPubMed
15. 15.↵
    1. Rauscher A,
    2. Barth M,
    3. Reichenbach JR,
    4. et al

    . Automated unwrapping of MR phase images applied to BOLD MR-venography at 3 Tesla. J Magn Reson Imaging 2003;18:175–80

    CrossRefPubMed
16. 16.↵
    1. Reichenbach JR,
    2. Haacke EM

    . High resolution BOLD venographic imaging: a window into brain function. NMR Biomed 2001;14:453–67

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Johnson G,
    2. Hutchison JM

    . The limitations of NMR recalled-echo imaging techniques. J Magn Reson 1985;63:14–30

    Web of Science
18. 18.↵
    1. Schaltenbrand G,
    2. Wahren W

    . Atlas for Stereotaxy of the Human Brain. Stuttgart, Germany: Thieme; 1977
19. 19.↵
    1. Mai JK,
    2. Paxinos G,
    3. Assheuer JK

    . Atlas of the Human Brain. 2nd ed. Amsterdam, the Netherlands: Elsevier; 2003
20. 20.↵
    1. Dormont D,
    2. Ricciardi KG,
    3. Tande D

    . Is the subthalamic nucleus hypointense on T2-weighted images? A correlation study using MR imaging and stereotactic atlas data. AJNR Am J Neuroradiol 2004;25:1516–23

    Abstract/FREE Full Text
21. 21.↵
    1. Slavin KV,
    2. Thulborn KR,
    3. Wess C,
    4. et al

    . Direct visualization of the human subthalamic nucleus with 3T MR imaging. AJNR Am J Neuroradiol 2006;27:80–84

    Abstract/FREE Full Text
22. 22.↵
    1. Young GS,
    2. Chen NK

    . High contrast susceptibility weighted imaging: Reliable Unwrapping Susceptibility Technique (RUST SWI) improved visualization of midbrain nuclei for deep brain stimulation. In: Proceedings of the 15th Annual Meeting of the International Society for Magnetic Resonance in Medicine, Berlin Germany. May 19–25, 2007:937
23. 23.↵
    1. Coenen VA,
    2. Prescher A,
    3. Schmidt,
    4. et al

    . What is dorso-lateral in the subthalamic nucleus (STN)? A topographic and anatomical consideration on the ambiguous description of today's primary target for deep brain stimulation (DBS) surgery. Acta Neurochirurgica (Wien) 2008;150:1163–65. Epub 2008 Oct 29

    CrossRef
24. 24.↵
    1. Coenen VA,
    2. Gielen F,
    3. Rohde I,
    4. et al

    . Subthalamic nucleus stimulation for advanced Parkinson's disease: how to find a far medial STN. Minim Invasive Neurosurg 2004;47:373–77

    CrossRefPubMed
25. 25.↵
    1. Paraskevi K,
    2. Argyopoulou MI,
    3. Markoula S,
    4. et al

    . MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease. J Neurol 2006;253:26–32

    CrossRefPubMedWeb of Science